TechWeb

Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call

Jan 10, 2008 (06:01 AM EST)
URL: http://www.techweb.com/show-press-release/X666590/pharsight-announces-fiscal-third-quarter-2008-earnings-release-date-and-conference-call.html

MOUNTAIN VIEW, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services for optimizing clinical drug development, announced today that it will release financial results for the fiscal third quarter 2008, which ended December 31, 2007, after the market closes on Thursday, January 24, 2008. The Company will host a conference call and webcast on Friday, January 25, 2008 at 10:00 a.m. Pacific Time to discuss the Company's fiscal third quarter results, and current corporate developments. The dial-in number for the conference call is 800-240-2134 for domestic participants and 303-262-2130 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers, using passcode 11106750# and 303-590-3000 for international callers, using passcode 11106750#. To access the live webcast of the call, go to Pharsight's website at http://www.pharsight.com http://www.pharsight.com . An archived webcast will also be available at .

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com .

CONTACT: investors, Jennifer Beugelmans, +1-646-201-5447, or Doug Sherk,+1-415-896-6820, or media, Steve DiMattia, +1-646-201-5445, all of EVCGroup, for Pharsight Corporation

Web site: http://www.pharsight.com/